Paul C Boutros

发表

SeqControl: process control for DNA sequencing

Robert E Denroche, John D McPherson, Lauren C Chong, 2014, Nature Methods.

Pathway-based subnetworks enable cross-disease biomarker discovery

Pietro Lio', John M S Bartlett, Philippe Lambin, 2018, Nature Communications.

Best practices for benchmarking germline small-variant calls in human genomes

Birgit Funke, Marc Salit, Justin M Zook, 2019, Nature Biotechnology.

VennDIS: A JavaFX‐based Venn and Euler diagram software to generate publication quality figures

Ankit Sinha, Thomas Kislinger, Paul C Boutros, 2015, Proteomics.

Web-based resources for clinical bioinformatics.

Paul C Boutros, Anthony M Joshua, P. Boutros, 2008, Methods in molecular medicine.

Author Correction: Best practices for benchmarking germline small-variant calls in human genomes

Birgit Funke, Marc Salit, Justin M Zook, 2019, Nature Biotechnology.

Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues

Wei Shi, Igor Jurisica, Paul C Boutros, 2009, Laboratory Investigation.

Systematic evaluation of medium-throughput mRNA abundance platforms.

Paul C Boutros, Raimo Pohjanvirta, John D. Watson, 2013, RNA.

Evaluation of various housekeeping genes for their applicability for normalization of mRNA expression in dioxin-treated rats.

Paul C Boutros, Ivy D Moffat, Raimo Pohjanvirta, 2006, Chemico-biological interactions.

Identification of Differentially Expressed Proteins in Direct Expressed Prostatic Secretions of Men with Organ-confined Versus Extracapsular Prostate Cancer*

Irina Kalatskaya, Thomas Kislinger, Paul C Boutros, 2012, Molecular & Cellular Proteomics.

The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.

Igor Jurisica, Irene L Andrulis, Paul C Boutros, 2006, Cancer research.

The path to routine use of genomic biomarkers in the cancer clinic

Paul C Boutros, P. Boutros, 2015, Genome research.

Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity

Igor Jurisica, Anthony Fyles, Paul C Boutros, 2006, Clinical Cancer Research.

Fast and Versatile Non-Negative Matrix Factorization

Paul C Boutros, Xihui Lin, 2016 .

Allele-Skewed DNA Modification in the Brain: Relevance to a Schizophrenia GWAS.

Arturas Petronis, Paul C Boutros, Sarah A. Gagliano, 2016, American journal of human genetics.

Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma.

Igor Jurisica, Richard Lehner, Paul C Boutros, 2010, Blood.

Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction

Quaid Morris, Paul C Boutros, Syed Haider, 2013, Genome Medicine.

Analysis of the Genetic Phylogeny of Multifocal Prostate Cancer Identifies Multiple Independent Clonal Expansions in Neoplastic and Morphologically Normal Prostate Tissue

Andrew Menzies, Keiran Raine, Rosalind Eeles, 2015, Nature Genetics.

Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection

Ken Chen, David Haussler, Justin Guinney, 2018, bioRxiv.

dbZach: A MIAME-compliant toxicogenomic supportive relational database.

Paul C Boutros, Lyle D Burgoon, Timothy R Zacharewski, 2006, Toxicological sciences : an official journal of the Society of Toxicology.

Prognostic gene signatures for non-small-cell lung cancer

Igor Jurisica, Paul C Boutros, Melania Pintilie, 2009, Proceedings of the National Academy of Sciences.

Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors

Philippe Lambin, Paul C Boutros, Johan Bussink, 2014, BMC Cancer.

Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity.

Paul C Boutros, Cindy Q Yao, Ivy D Moffat, 2011, Toxicology and applied pharmacology.

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer

Jouhyun Jeon, Thomas Kislinger, Paul C Boutros, 2016, Nature Communications.

Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies

Igor Jurisica, Thomas John, Philippe Lambin, 2012, Genome Medicine.

Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Christine P'ng, Nicholas J Harding, Paul C Boutros, 2012, Toxicology and applied pharmacology.

Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.

Mathieu Lupien, Michael D. Wilson, Paul C Boutros, 2020, Molecular cell.

Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting.

Paul C Boutros, Ivy D Moffat, Raimo Pohjanvirta, 2004, Biochemical and biophysical research communications.

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.

Igor Jurisica, Mark J Dunning, Emilie Lalonde, 2014, The Lancet. Oncology.

Epigenetics in radiotherapy: where are we heading?

Esther G C Troost, Philippe Lambin, Paul C Boutros, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Toward better benchmarking: challenge-based methods assessment in cancer genomics

Andrea Califano, Joshua M. Stuart, Gustavo Stolovitzky, 2014, Genome Biology.

Three-gene prognostic classifier for early-stage non small-cell lung cancer.

Igor Jurisica, Shaf Keshavjee, Paul C Boutros, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer.

Arek Kasprzyk, Francis Nguyen, Philippe Lambin, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Spatial genomic heterogeneity within localized, multifocal prostate cancer

Faraz Hach, Robert E Denroche, Neil Fleshner, 2015, Nature Genetics.